FDA Inspection 1115640 — Watson Pharma Private Limited

Watson Pharma Private Limited — FEI 3005719315

The FDA completed an inspection of Watson Pharma Private Limited on January 23, 2020 in Verna. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 23, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Verna (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
203121 CFR 211.194(a)Complete test data included in records
362921 CFR 211.170(b)Reserve samples identified, representative, stored
440221 CFR 211.192Written record of investigation incomplete